Glaucoma progression. Clinical practice guide.

Objective: To provide general recommendations that serve as a guide for the evaluation and management of glaucomatous progression in daily clinical practice based on the existing quality of clinical evidence.

Methods: After defining the objectives and scope of the guide, the working group was formed and structured clinical questions were formulated following the PICO (Patient, Intervention, Comparison, Outcomes) format. Once all the existing clinical evidence had been independently evaluated with the AMSTAR 2 (Assessment of Multiple Systematic Reviews) and Cochrane "Risk of bias" tools by at least two reviewers, recommendations were formulated following the Scottish Intercollegiate Guideline network (SIGN) methodology.

Advanced glaucoma. Clinical practice guideline.

Objective: To present an update clinical practice guideline that serve as a guide for the detection, evaluation and treatment of adults patients with advanced glaucoma.

Methods: After defining the objectives and scope of the guide, the working group was formed and structured clinical questions were formulated following the PICO (Patient, Intervention, Comparison, Outcomes) format. Once all the existing clinical evidence had been independently evaluated with the AMSTAR 2 (Assessment of Multiple systematic Rewiews) and Cochrane "Risk of bias" tools by at least two reviewers, recommendations were formulated following the Scottish Intercollegiate methodology.

Ocular toxicity after inadvertent overdose of intracameral cefuroxime during cataract surgery.

Purpose: To describe intracameral toxic effects of cefuroxime at a higher dose than recommended in cataract surgery.

Methods: Retrospective study of 8 eyes of 8 patients who inadvertently received 12.5 mg/0.

Ocular toxicity after inadvertent overdose of intracameral cefuroxime during cataract surgery.

Purpose: To describe intracameral toxic effects of cefuroxime at a higher dose than recommended in cataract surgery.

Methods: Retrospective study of 8 eyes of 8 patients who inadvertently received 12.5mg/0.